Cammarota, Giovanni
 Distribuzione geografica
Continente #
NA - Nord America 14.586
EU - Europa 14.058
AS - Asia 11.932
SA - Sud America 2.299
AF - Africa 269
Continente sconosciuto - Info sul continente non disponibili 36
OC - Oceania 36
Totale 43.216
Nazione #
US - Stati Uniti d'America 14.131
DE - Germania 5.740
SG - Singapore 5.296
CN - Cina 2.906
IT - Italia 2.027
BR - Brasile 1.872
SE - Svezia 1.576
VN - Vietnam 1.040
FR - Francia 1.036
UA - Ucraina 846
GB - Regno Unito 699
IE - Irlanda 485
IN - India 414
PL - Polonia 402
BD - Bangladesh 388
FI - Finlandia 372
JP - Giappone 353
ID - Indonesia 352
RU - Federazione Russa 272
HK - Hong Kong 256
CA - Canada 220
TR - Turchia 209
AR - Argentina 165
NL - Olanda 130
MX - Messico 126
IQ - Iraq 116
ES - Italia 98
KR - Corea 91
BE - Belgio 87
ZA - Sudafrica 60
PK - Pakistan 59
EC - Ecuador 56
CO - Colombia 52
VE - Venezuela 52
AT - Austria 50
SA - Arabia Saudita 48
CH - Svizzera 41
UZ - Uzbekistan 41
MA - Marocco 36
CZ - Repubblica Ceca 35
IR - Iran 34
JO - Giordania 33
TN - Tunisia 33
IL - Israele 32
CL - Cile 31
KE - Kenya 30
AE - Emirati Arabi Uniti 29
AU - Australia 29
LT - Lituania 28
PH - Filippine 28
EU - Europa 27
PY - Paraguay 25
EG - Egitto 24
KZ - Kazakistan 20
NP - Nepal 19
AZ - Azerbaigian 18
DZ - Algeria 17
JM - Giamaica 17
PA - Panama 17
PT - Portogallo 17
RO - Romania 17
PE - Perù 16
BH - Bahrain 14
CI - Costa d'Avorio 14
CR - Costa Rica 14
OM - Oman 14
TW - Taiwan 14
BO - Bolivia 13
UY - Uruguay 13
MY - Malesia 12
TH - Thailandia 12
GR - Grecia 11
HR - Croazia 11
LK - Sri Lanka 11
HU - Ungheria 10
LB - Libano 10
RS - Serbia 10
DO - Repubblica Dominicana 9
ET - Etiopia 9
GE - Georgia 9
TT - Trinidad e Tobago 9
AL - Albania 8
GT - Guatemala 8
NG - Nigeria 8
BY - Bielorussia 7
HN - Honduras 7
NI - Nicaragua 7
BB - Barbados 6
BG - Bulgaria 6
KG - Kirghizistan 6
KW - Kuwait 6
SK - Slovacchia (Repubblica Slovacca) 6
SN - Senegal 6
SY - Repubblica araba siriana 6
AO - Angola 5
CY - Cipro 5
NZ - Nuova Zelanda 5
PS - Palestinian Territory 5
XK - ???statistics.table.value.countryCode.XK??? 5
BZ - Belize 4
Totale 43.111
Città #
Singapore 2.744
Chandler 1.777
Ashburn 1.551
San Jose 1.437
Beijing 491
Jacksonville 489
Dublin 477
San Mateo 383
Nürnberg 378
Ann Arbor 359
Ho Chi Minh City 346
New York 345
Los Angeles 330
Hefei 327
Rome 320
Jakarta 318
Lauterbourg 315
Nanjing 302
Tokyo 302
Warsaw 282
Milan 255
Hanoi 254
Woodbridge 232
Hong Kong 231
Boston 228
Wilmington 227
Munich 215
Frankfurt am Main 194
Cattolica 188
Marseille 168
Dearborn 167
Princeton 152
Houston 150
São Paulo 148
Moscow 138
Fairfield 136
Izmir 134
Seattle 133
Chicago 132
The Dalles 131
Buffalo 128
St Louis 127
Dallas 126
Redwood City 124
Boardman 117
Santa Clara 115
Nanchang 113
Council Bluffs 110
Helsinki 105
Kent 90
Lawrence 89
Shanghai 86
Seoul 84
Brussels 79
London 76
Kraków 75
Turku 75
Shenyang 74
Hangzhou 71
Fuzhou 68
Rio de Janeiro 65
Orem 64
Toronto 61
Verona 60
Guangzhou 59
Lancaster 59
Redmond 59
Nuremberg 58
Paris 58
Bremen 57
Brooklyn 57
Hebei 57
Mountain View 54
Leawood 52
Da Nang 51
Denver 50
Pune 50
Atlanta 49
Baghdad 49
Belo Horizonte 49
Phoenix 49
Tianjin 49
Zhengzhou 49
Changsha 47
Kunming 47
Las Vegas 47
Montreal 46
Stockholm 45
University Park 44
Memphis 43
San Francisco 43
Cambridge 41
Amsterdam 40
Haiphong 40
Düsseldorf 38
Norwalk 38
Fremont 36
Johannesburg 36
North Bergen 35
Augusta 34
Totale 20.783
Nome #
-Rifaximin dose-finding study for the treatment of small intestinal bacterial overgrowth 508
Small intestinal bacterial overgrowth recurrence after antibiotic therapy 437
A case-control study comparing methylene blue directed biopsies and random biopsies for detecting pre-cancerous lesions in the follow-up of gastric cancer patients 433
Image-Enhanced Endoscopy with I-scan Technology for the Evaluation of Duodenal Villous Patterns 433
Consorzio di probiotici / Probiotic mixture 373
Gut microbial flora, prebiotics, and probiotics in IBD: their current usage and utility 372
gc) Water-immersion technique during standard upper endoscopy may be useful to drive the biopsy sampling of duodenal mucosa in children with celiac disease. 308
Gut microbiota in anxiety and depression: Pathogenesis and therapeutics 299
International consensus conference on stool banking for faecal microbiota transplantation in clinical practice 277
ag)Association between hypothyroidism and small intestinal bacterial overgrowth 270
A) Lack of endoscopic visualization of intestinal villi with the "immersion technique" in overt atrophic celiac disease 265
High accuracy and cost-effectiveness of a biopsy-avoiding endoscopic approach in diagnosing coeliac disease. 259
A highly accurate method for monitoring histological recovery in patients with celiac disease on a gluten-free diet using an endoscopic approach that avoids the need for biopsy: a double-center study 252
gc) Increased intestinal permeability and tight junction alterations in nonalcoholic fatty liver disease. 247
Wheat desensitization treatment in patients with gluten sensitivity 242
gc) Biofilm demolition and antibiotic treatment to eradicate resistant Helicobacter pylori: a clinical trial. 240
Nutrition and IBD: Malnutrition and/or Sarcopenia? A Practical Guide 233
Effect of Lactobacillus GG supplementation on antibiotic-associated gastrointestinal side effects during Helicobacter pylori eradication therapy: a pilot study 231
A) Bacillus clausii therapy to reduce side-effects of anti-Helicobacter pylori treatment: randomized, double-blind, placebo controlled trial. 230
-High prevalence of celiac disease in patients with lactose intolerance 230
The involvement of gut microbiota in inflammatory bowel disease pathogenesis: Potential for therapy 222
T-bet and pSTAT1 expression in peripheral blood mononuclear cells from coeliac disease patients: new markers of disease activity 221
The role of diet on gut microbiota composition 216
-Moxifloxacin-based strategies for first-line treatment of Helicobacter pylori infection. 215
A) Reliability of the "immersion technique" during routine upper endoscopy for detection of abnormalities of duodenal villi in patients with dyspepsia. 213
gc) Patchy left-sided colitis: primary eosinophilic colitis or paraneoplastic syndrome ? 212
The first international Rome consensus conference on gut microbiota and faecal microbiota transplantation in inflammatory bowel disease 210
Can chronic gastritis cause an increase in fecal calprotectin concentrations? 210
Nickel free-diet enhances the Helicobacter pylori eradication rate: a pilot study. 209
Donor program for fecal microbiota transplantation: A 3-year experience of a large-volume Italian stool bank 209
Role and mechanisms of action of Escherichia coli nissle 1917 in the maintenance of remission in ulcerative colitis patients: an update 208
Decrease in Surgery for Clostridium difficile Infection After Starting a Program to Transplant Fecal Microbiota 207
(gc)Association of laryngeal cancer with previous gastric resection. 205
Diagnostic and therapeutic impact of double-balloon enteroscopy (DBE) in a series of 100 patients with suspected small bowel diseases 205
GC)Optimal band imaging system: a new tool for enhancing the duodenal villous pattern in celiac disease. 204
Non-alcoholic fatty liver disease is associated with high prevalence of gastro-oesophageal reflux symptoms 201
Non-alcoholic fatty liver disease is associated with high prevalence of gastro-oesophageal reflux symptoms 201
Levofloxacin-based triple therapy in first-line treatment for Helicobacter pylori eradication 200
Identification of spatially-resolved markers of malignant transformation in Intraductal Papillary Mucinous Neoplasms 198
Gut Microbiota in Health, Diverticular Disease, Irritable Bowel Syndrome, and Inflammatory Bowel Diseases: Time for Microbial Marker of Gastrointestinal Disorders? 198
Celiac disease: what's new about it? 195
Fecal microbiota transplantation: Past, present and future perspectives 192
Gut microbiome, big data and machine learning to promote precision medicine for cancer 192
Combined atherogenic effects of celiac disease and type 1 diabetes mellitus 191
Dramatic improvement of parkinsonian symptoms after gluten-free diet introduction in a patient with silent celiac disease 191
. Adverse reactions to food: allergies and intolerances. 188
Helicobacter pylori eradication rate and glycemic control in young patients with type 1 diabetes 187
Increased expression of T-bet in circulating B cells from a patient with multiple sclerosis and celiac disease 186
A) Association of laryngeal cancer with previous gastric resection 185
Can chronic gastritis cause increase of fecal calprotectin concentrations? 183
Nickel free-diet enhances the Helicobacter pylori eradication rate: a pilot study 181
Efficacy and Mechanisms of Action of Fecal Microbiota Transplantation in Ulcerative Colitis: Pitfalls and Promises From a First Meta-Analysis 181
Combined atherogenic effects of celiac disease and type 1 diabetes mellitus 179
Classification of malabsorption syndromes. 177
gc) Celiac disease in the 21st century: issues of under- and over-diagnosis 176
Fecal calprotectin concentrations in patients with small intestinal bacterial overgrowth. 175
Levofloxacin-based triple therapy vs. quadruple therapy in second-line Helicobacter pylori treatment: a randomized trial. 175
Image-Enhanced Endoscopy with I-scan Technology for the Evaluation of Duodenal Villous Patterns. 173
Histamine-producing bacteria and their role in gastrointestinal disorders 172
A) High levels of dual resistance to clarithromycin and metronidazole and in vitro activity of levofloxacin against Helicobacter pylori isolates from patients after failure of therapy. 171
-Abnormal breath tests to lactose, fructose and sorbitol in irritable bowel syndrome may be explained by small intestinal bacterial overgrowth 170
Fine-tuning the gut ecosystem: the current landscape and outlook of artificial microbiome therapeutics 168
-Double-balloon enteroscopy for diagnosis of a Meckel's diverticulum in a patient with GI bleeding of obscure origin 168
ag) Fecal calprotectin in first-degree relatives of patients with ulcerative colitis. 168
Key determinants of success in fecal microbiota transplantation: From microbiome to clinic 167
Fecal calprotectin concentrations in patients with small intestinal bacterial overgrowth. 167
Probiotics, fibre and herbal medicinal products for functional and inflammatory bowel disorders 167
[Helicobacter pylori infection: from gastric to systemic disease] 166
Image-enhanced endoscopy with I-scan technology for the evaluation of duodenal villous patterns 166
Locally injected Infliximab ameliorates murine DSS colitis: differences in serum and intestinal levels of drug between healthy and colitic mice 166
Donor screening for fecal microbiota transplantation with a direct stool testing-based strategy: a prospective cohort study 164
Relationship between gastric localization of hepatitis C virus and mucosa-associated lymphoid tissue in Helicobacter pylori infection 164
High dosage rifaximin for the treatment of small intestinal bacterial overgrowth. 164
Improved gut microbiota features after the resolution of SARS‑CoV‑2 infection 164
Fecal calprotectin in first-degree relatives of patients with ulcerative colitis 163
Randomised clinical trial: faecal microbiota transplantation by colonoscopy vs. vancomycin for the treatment of recurrent Clostridium difficile infection. 163
FETR-ALS Study Protocol: A Randomized Clinical Trial of Fecal Microbiota Transplantation in Amyotrophic Lateral Sclerosis 163
Cystic lymphangioma of the mesentery and hyposplenism in celiac disease. 161
Microscopic colitis 161
gc) Tired legs a gut diagnosis 160
The role of IL-15 in gastrointestinal diseases: a bridge between innate and adaptive immune response 160
Predictors of failure after single faecal microbiota transplantation in patients with recurrent Clostridium difficile infection: results from a three-year, single-centre cohort study 160
The Detrimental Impact of Ultra-Processed Foods on the Human Gut Microbiome and Gut Barrier 159
. Quick test: a new test for the diagnosis of duodenal hypolactasia. 159
Post-cholecystectomy alkaline reactive gastritis: a randomized trial comparing sucralfate versus rabeprazole or no treatment 159
A) Gastric surgery as a long-term risk factor for malignant lesions of the larynx. 158
European consensus conference on faecal microbiota transplantation in clinical practice 158
Effect of different probiotic preparations on anti-helicobacter pylori therapy-related side effects: a parallel group, triple blind, placebo-controlled study 157
Tissue-infiltrating lymphocytes analysis reveals large modifications of the duodenal "immunological niche" in coeliac disease after gluten-free diet. 157
Prophylactic aspirin therapy does not increase faecal calprotectin concentrations. 156
Gluten-related Recurrent Peripheral Facial Palsy 156
Link between Helicobacter pylori infection and iron-deficiency anaemia in patients with coeliac disease 156
Faecal calprotectin concentrations in untreated coeliac patients 156
The Role of Antibiotics in Gut Microbiota Modulation: The Eubiotic Effects of Rifaximin 155
Levofloxacin based regimens for the eradication of Helicobacter pylori 154
gastroesophageal reflux disease: facts and uncertaines 154
-Accuracy of laryngeal examination during upper gastrointestinal endoscopy for premalignancy screening: prospective study in patients with and without reflux symptoms. 152
Locally injected Infliximab ameliorates murine DSS colitis: differences in serum and intestinal levels of drug between healthy and colitic mice 151
Body mass index influences infliximab post-infusion levels and correlates with prospective loss of response to the drug in a cohort of inflammatory bowel disease patients under maintenance therapy with Infliximab 151
Intestinal Permeability and Dysbiosis in Female Patients with Recurrent Cystitis: A Pilot Study 150
Totale 20.371
Categoria #
all - tutte 169.965
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 169.965


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202167 0 0 0 0 0 0 0 0 0 0 0 67
2021/20222.093 117 185 57 129 130 89 39 337 97 95 388 430
2022/20234.882 628 658 365 732 320 599 247 386 596 94 159 98
2023/20242.645 133 704 90 173 119 318 175 95 70 156 322 290
2024/20255.946 148 198 470 167 456 189 165 326 831 588 1.257 1.151
2025/202616.421 2.423 534 951 1.672 2.551 1.127 2.691 806 1.084 1.128 776 678
Totale 43.722